Human medicines European public assessment report (EPAR): Symkevi, tezacaftor,ivacaftor, Date of authorisation: 31/10/2018, Revision: 16, Status: Authorised

Applications for new human medicines under evaluation: October 2024

Human medicines European public assessment report (EPAR): Oxbryta, Voxelotor, Date of authorisation: 14/02/2022, Revision: 5, Status: Suspended

Antimicrobial Sales and Use (ASU) Platform: Release notes

PSUSA/00010866/202401

European Medicines Agency post-authorisation procedural advice for users of the centralised procedure

CHMP early contact with patient and healthcare professional organisations: process and FAQs

Referral: Lorazepam Macure 4 mg/ml, solution for injection, lorazepam Article 13 referrals European Commission final decision, 27/06/2024, 29/08/2024, 08/10/2024

Multistakeholder workshop on shortages of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 July 2024, 12:30 (CEST) to 1 July 2024, 18:30 (CEST)

Tenth Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2024, 09:00 (CEST) to 26 September 2024, 13:25 (CEST)